Sharp et al; “Integrating fragment-based screening with targeted protein degradation and genetic rescue to explore eIF4E function”; Nat Commun., 2025

/in , , ,

Sharp et al; “Integrating fragment-based screening with targeted protein degradation and genetic rescue to explore eIF4E function”; Nat Commun., 2025

https://doi.org/10.1038/s41467-024-54356-1

Holvey et al; “Fragment-to-Lead Medicinal Chemistry Publications in 2023”; J. Med. Chem., 2025

/in , , ,

Holvey et al; “Fragment-to-Lead Medicinal Chemistry Publications in 2023”; J. Med. Chem., 2025

https://doi.org/10.1021/acs.jmedchem.4c02593

Martins et al; “The preclinical pharmacokinetics of Tolinapant—A dual cIAP1/XIAP antagonist with in vivo efficacy” Pharmacol Res Perspect, 2024

/in , , , ,

Martins et al; “The preclinical pharmacokinetics of Tolinapant—A dual cIAP1/XIAP antagonist with in vivo efficacy” Pharmacol Res Perspect, 2024

https://doi.org/10.1002/prp2.70030

 

Ramos et al; “Proteome-wide CETSA reveals diverse apoptosis-inducing mechanisms converging on an initial apoptosis effector stage at the nuclear periphery” Cell Reports, 2024

/in ,

Ramos et al; “Proteome-wide CETSA reveals diverse apoptosis-inducing mechanisms converging on an initial apoptosis effector stage at the nuclear periphery” Cell Reports, 2024

https://doi.org/10.1016/j.celrep.2024.114784

Palmer et al; “Fragment-Based Discovery of a Series of Allosteric-Binding Site Modulators of β-Glucocerebrosidase” J Med Chem, 2024

/in ,

Palmer et al; “Fragment-Based Discovery of a Series of Allosteric-Binding Site Modulators of β-Glucocerebrosidase” J Med Chem, 2024

https://doi.org/10.1021/acs.jmedchem.4c00702

Gustavvson et al; “The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1” Science Advances, 2024

/in ,

Gustavvson et al; “The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1” Science Advances, 2024

https://www.science.org/doi/10.1126/sciadv.adk1296?

Ma et al; “Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRASG12C Inhibitor” J. Med. Chem. 2024

/in ,

Ma et al; “Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRASG12C Inhibitor” J. Med. Chem. 2024

https://doi.org/10.1021/acs.jmedchem.4c00572

Mukherjee, et al; “Protein engineering enables a soakable crystal form of human CDK7 primed for high-throughput crystallography and structure-based drug design”; Structure. 2024

/in ,

Mukherjee, et al; “Protein engineering enables a soakable crystal form of human CDK7 primed for high-throughput crystallography and structure-based drug design”; Structure. 2024

https://doi.org/10.1016/j.str.2024.05.011

Sanchez-Garcia et al; “CESPED: A benchmark for supervised particle pose estimation in cryo-EM” Physical Review Research. 2024

/in ,

Sanchez-Garcia et al; “CESPED: A benchmark for supervised particle pose estimation in cryo-EM” Physical Review Research. 2024

https://doi.org/10.1103/PhysRevResearch.6.023245